Vanda Pharmaceuticals Inc (VNDA)

Jun 15, 2026

Watch VANDA Pharmaceuticals Berlin Tennis Open / Court 1 | Disney+ - Disney Plus

Jun 15, 2026

Jun 15, 2026

Why Did Vanda Pharmaceuticals Stock Slide 7% Pre-Market Today? - Stocktwits

Jun 15, 2026

Jun 14, 2026

Watch VANDA Pharmaceuticals Berlin Tennis Open / Steffi Graf Stadion | Disney+ - Disney Plus

Jun 14, 2026

Jun 14, 2026

VNDA Stock Soars 40% Overnight After Bysanti Approval: What’s The Next Catalyst And How Much Upside Remains? - Stocktwits

Jun 14, 2026

Jun 13, 2026

Vanda Stock Draws Heavy Buzz Ahead Of FDA Verdict On Bysanti For Bipolar, Schizophrenia - Stocktwits

Jun 13, 2026

Jun 12, 2026

Vanda Pharmaceuticals Stock Price Forecast. Should You Buy VNDA? - StockInvest.us

Jun 12, 2026

Jun 11, 2026

VNDA Stock Rises After Hours On Commercial Launch Of Motion Sickness Drug - Stocktwits

Jun 11, 2026

Jun 08, 2026

VNDA Stock Rallies After-Hours As FDA Approves Schizophrenia, Bipolar Disorder Drug - Stocktwits

Jun 08, 2026

Jun 08, 2026

80,000-share RSU grant to Vanda (VNDA) SVP and General Counsel - Stock Titan

Jun 08, 2026

Jun 08, 2026

Vanda Pharmaceuticals (VNDA) director granted 41,600 RSU shares vesting in 2027 - Stock Titan

Jun 08, 2026

Jun 08, 2026

Vanda (NASDAQ: VNDA) director awarded 41,600 RSU-based shares - Stock Titan

Jun 08, 2026

Jun 08, 2026

Vanda Pharmaceuticals (VNDA) director receives 41,600-share RSU award - Stock Titan

Jun 08, 2026

Jun 08, 2026

Vanda Pharmaceuticals (VNDA) director receives 41,600-share RSU grant - Stock Titan

Jun 08, 2026

Jun 08, 2026

Vanda Pharmaceuticals (VNDA) grants director 41,600 RSUs vesting in 2027 - Stock Titan

Jun 08, 2026

Jun 08, 2026

Vanda Pharmaceuticals (VNDA) SVP McGuire reports RSU awards vesting through 2029 - Stock Titan

Jun 08, 2026

Jun 06, 2026

Vanda Pharma Stock Rises Pre-Market After FDA Accepts Imsidolimab Filing For Rare Skin Disorder - Stocktwits

Jun 06, 2026

Jun 06, 2026

Vanda Pharmaceuticals 2026 Annual Meeting Results: Director Elections, Auditor Ratification, and Plan Amendment Approved - minichart.com.sg

Jun 06, 2026

Jun 05, 2026

Vanda (NASDAQ: VNDA) investors approve directors, auditor and equity plan shares - Stock Titan

Jun 05, 2026

Jun 05, 2026

Earnings call transcript: Vanda Pharmaceuticals misses Q1 2026 forecasts, stock rises - Investing.com

Jun 05, 2026

Jun 05, 2026

Analysts Offer Insights on Healthcare Companies: Vanda (VNDA), ArriVent BioPharma, Inc. (AVBP) and Medtronic (MDT) - The Globe and Mail

Jun 05, 2026

Jun 04, 2026

Gastroparesis Market Shows Strong Future Potential with Increasing Industry Investments by 2036 – DelveInsight | Vanda Pharma, Dr. Falk Pharma GmbH, Alfasigma S.p.A., PTC Therapeutics, CinDome Pharma - Barchart.com

Jun 04, 2026

Jun 04, 2026

Gastroparesis Market Shows Strong Future Potential with - openPR.com

Jun 04, 2026

Jun 04, 2026

Vanda Pharmaceuticals stock rating reiterated at Buy by H.C. Wainwright - Investing.com

Jun 04, 2026

May 30, 2026

Why did Vanda Pharmaceuticals stock slide 7% pre-market today? - MSN

May 30, 2026

May 29, 2026

Earnings call transcript: Vanda Pharmaceuticals Q1 2026 misses EPS forecast, stock drops - Investing.com Nigeria

May 29, 2026

May 28, 2026

Vanda Pharmaceuticals (VNDA) Shares Rise 3.75% as Stock Tests Key ResistanceWMA Signal - The Legal Advocate

May 28, 2026

May 28, 2026

H.C. Wainwright Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Maintains Target Price $21 - Moomoo

May 28, 2026

May 27, 2026

Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan - GuruFocus

May 27, 2026

May 27, 2026

Vanda gets orphan drug status in Japan for imsidolimab By Investing.com - Investing.com Australia

May 27, 2026

May 27, 2026

Vanda Pharmaceuticals (VNDA) Secures Orphan Drug Status in Japan - GuruFocus

May 27, 2026

May 27, 2026

Vanda gets orphan drug status in Japan for imsidolimab - Investing.com

May 27, 2026

May 27, 2026

Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis - Barchart

May 27, 2026

May 23, 2026

Vanda a new buy at B. Riley on 'historic discount' - MSN

May 23, 2026

May 22, 2026

Vanda Pharmaceuticals Inc (VNDA) Stock Price, Quote, News & History - Benzinga

May 22, 2026

May 20, 2026

Vanda Pharmaceuticals Q3 Earnings Preview - MSN

May 20, 2026

May 20, 2026

Vanda (VNDA) director donates 25,836 shares of common stock - Stock Titan

May 20, 2026

May 19, 2026

VNDA: 2026 revenue guidance raised on new launches, with BYSANTI and NEREUS set to drive future growth - TradingView

May 19, 2026

May 17, 2026

How The Vanda Pharmaceuticals (VNDA) Investment Story Is Shifting With BYSANTI And Nereus - Yahoo Finance

May 17, 2026

May 16, 2026

Vanda Pharmaceuticals stock (US92178N1054): Regulatory setback, sharp drop and rising short interest - AD HOC NEWS

May 16, 2026

May 13, 2026

Vanda: A Long-Term Pharma Growth Idea, Despite Q1 Earnings Miss (NASDAQ:VNDA) - Seeking Alpha

May 13, 2026

May 13, 2026

Vanda targets $240M-$290M 2026 revenue as it introduces $10M-$30M NEREUS sales outlook - MSN

May 13, 2026

May 13, 2026

HC Wainwright Brokers Lower Earnings Estimates for VNDA - MarketBeat

May 13, 2026

May 12, 2026

State Street (VNDA) discloses 3.02M shares, 5.1% ownership on 13G - Stock Titan

May 12, 2026

May 12, 2026

Earnings call transcript: Vanda Pharmaceuticals Q1 2026 misses EPS forecast, stock drops By Investing.com - Investing.com South Africa

May 12, 2026